Brief: Niagen Bioscience Acquires Existing Core Nicotinamide Riboside Patent Portfolio From Queen’S University Belfast
22/12/2025 13:44
Dec 22 (Reuters) - Niagen Bioscience Inc NAGE.O: NIAGEN BIOSCIENCE ACQUIRES EXISTING CORE NICOTINAMIDE RIBOSIDE (NR) PATENT PORTFOLIO FROM QUEEN’S UNIVERSITY BELFAST Source text: ID:nBw5HpMsFa Further company coverage: NAGE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Niagen Bioscience
See all newsAs weight-loss drug users turn to dietary supplements, doctors, regulators raise flags
Niagen Bioscience Inc reports results for the quarter ended June 30 - Earnings Summary
Niagen Bioscience Q2 net sales fall, missing estimates
Niagen Bioscience Inc expected to post earnings of 2 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-SpaceX, Sandisk, Salesforce